Coherus Rolls Out YUSIMRY At $995 Per Carton In US

RTTNews | 1227 hari yang lalu
Coherus Rolls Out YUSIMRY At $995 Per Carton In US

(RTTNews) - Coherus BioSciences, Inc. (CHRS) announced Monday that YUSIMRY (adalimumab-aqvh) is now available for commercial sale in the United States at a list price of $995 per carton for two 40 mg/0.8 mL autoinjectors.

The pricing represents a discount of more than 85% to Humira (adalimumab), currently priced at $6,922 per carton of two pens.

YUSIMRY is presented in a state-of-the-art autoinjector and includes Coherus' proprietary non-stinging, citrate-free formulation and a 29-gauge needle.

YUSIMRY, approved in 2021 by the U.S. Food and Drug Administration, is a tumor necrosis factor blocker indicated to reduce the signs and symptoms of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and ankylosing spondylitis, and to treat Crohn's disease, ulcerative colitis, plaque psoriasis and hidradenitis suppurativa.

YUSIMRY Solutions - Coherus' patient services platform - will ensure improved access and a fast and seamless experience as patients start or switch to YUSIMRY treatment based on a determination by their healthcare provider.

baca selengkapnya
Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

Coherus BioSciences, Inc. (CHRS) and Shanghai Junshi Biosciences Co., Ltd. announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) resubmission for toripalimab in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma (NPC) and for toripalimab monotherapy for the second-line or later treatment of recurrent or metastatic NPC after platinum-containing chemotherapy.
RTTNews | 1589 hari yang lalu
FTSE 100 Rebounds

FTSE 100 Rebounds

The FTSE 100 benchmark rebounded on Wednesday amidst a surge in technology shares. A spike in crude oil prices bolstered energy stocks. Anxiety ahead of GDP update on Thursday limited gains.
RTTNews | 4 jam 11 menit yang lalu
CAC 40 Extends Winning Streak

CAC 40 Extends Winning Streak

A rally in global stock markets powered by the surge in technology shares helped the CAC 40 index to extend its winning streak.
RTTNews | 5 jam 13 menit yang lalu
Siemens Energy Gains On Strong Q4, Positive Outlook, Dividend Hike, €9 Bln Buyback

Siemens Energy Gains On Strong Q4, Positive Outlook, Dividend Hike, €9 Bln Buyback

Shares of Siemens Energy AG were gaining around 8 percent in the German trading after the company reported Wednesday significantly higher profit in its fourth quarter with revenue growth, and issued positive outlook for fiscal 2027 and ahead. The German energy technology firm also announced significantly higher dividend and up to an additional €9 billion share buyback program.
RTTNews | 5 jam 54 menit yang lalu
DAX Extends Gains On Wednesday

DAX Extends Gains On Wednesday

Lifted by the momentum in technology stocks, the DAX benchmark is close to recording a three-day gaining streak. Positive earnings scorecard also supported market sentiment.
RTTNews | 6 jam 7 menit yang lalu
U.S. Dollar Rallies Amid Fed Rate-hike Bets

U.S. Dollar Rallies Amid Fed Rate-hike Bets

The U.S. dollar strengthened against other major currencies in the European session on Wednesday, as hotter-than-expected U.S. inflation statistics increased anticipation that the Federal Reserve will raise borrowing costs next month.
RTTNews | 6 jam 57 menit yang lalu
U.S. Dollar Rises Against Majors

U.S. Dollar Rises Against Majors

The U.S. dollar strengthened against other major currencies in the European session on Wednesday.
RTTNews | 7 jam 13 menit yang lalu
Indian Shares Hit Eight-month High Amid Sharp Fall In Oil Prices

Indian Shares Hit Eight-month High Amid Sharp Fall In Oil Prices

Indian shares rose sharply on Wednesday to hit an eight-month high, with investor sentiment boosted by continued foreign fund inflows, a moderation of the AI trade, and a retreat in crude oil prices to two-month lows on hopes for a de-escalation in the U.S.-Israeli war on Iran.
RTTNews | 7 jam 49 menit yang lalu